4 mm pen needles evidence interface and design implications
Needle length is a clinical-use variable; compatibility is also a mechanical interface and system-verification question.
What the research found
A randomized crossover study in adults with obesity found that a 4 mm × 32G needle provided glycemic control equivalent to longer comparators, with less reported pain and similar leakage. Ultrasound-based research separately estimated lower intramuscular-injection risk with shorter needles.
Connection to Penacta
Several catalog platforms reference needles conforming to ISO 11608-2. That is a starting point, not proof that every needle is compatible with every final device and drug combination.
The 3 mL platforms in the catalogue, such as the 60-unit disposable platform and the 80-unit reusable platform, state their needle interface precisely because that interface is what has to be confirmed against your chosen needle.
Research basis
Bergenstal et al. Safety and efficacy of insulin therapy delivered via a 4 mm pen needle. PMID 25662503.Hirsch et al. Intramuscular risk at insulin injection sites. PMID 25329935.Sources reviewed
Peer reviewed records used to frame the article and its limitations
Define the needle interface
Screen the intended pen needle and container as a system.
Review pen platforms →